Krystal Biotech, Inc. · NASDAQ:KRYS
Krystal Biotech, Inc. shareholders
As of Jun 30, 2026, 409 institutions reported holding Krystal Biotech, Inc., 100.0% of its shares. Largest: Fidelity, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Krystal Biotech, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 4.42M | 14.9% | +44,210 | Aug 13, 2026 |
| BlackRock | 4.18M | 14.1% | +241K | Aug 7, 2026 |
| Vanguard | 3.05M | 10.3% | +206K | Aug 13, 2026 |
| Avoro Capital Advisors LLC | 2.89M | 9.8% | no change | Aug 14, 2026 |
| State Street | 1.35M | 4.6% | +36,724 | Aug 7, 2026 |
| Soleus Capital Management, L.P. | 939K | 3.2% | −214K | Aug 11, 2026 |
| Capital Group | 778K | 2.6% | −46,877 | Aug 12, 2026 |
| Geode Capital | 699K | 2.4% | +55,018 | Aug 12, 2026 |
| T. Rowe Price | 687K | 2.3% | +202K | Aug 14, 2026 |
| Hood River Capital Management LLC | 663K | 2.2% | +43,789 | Aug 14, 2026 |